Do calcium channel blockers have any influence on the immunological status of renal graft recipients on ciclosporin therapy?

Mandreoli, M; Esposti, E D; Cocchi, R; Fabbri, A; Guerrini, L; Fusaroli, M

Mandreoli, M; Esposti, E D; Cocchi, R; Fabbri, A; Guerrini, L; Fusaroli, M.

Affiliation

Mandreoli M; Department of Nephrology, S. Maria delle Croci Hospital, Ravenna, Italy.

Am J Nephrol ; 10(1): 58-60, 1990.

Article in En | MEDLINE | ID: mdl-1693039

Subject(s)

Adjuvants, Immunologic; Cyclosporins/therapeutic use; Diltiazem/pharmacology; Kidney Transplantation/immunology; Nicardipine/pharmacology; Adult; Cyclosporins/blood; Epitopes; Female; Humans; Leukocyte Count; Lymphocyte Activation; Male; Middle Aged; Phenylhydrazines/pharmacology; T-Lymphocytes/drug effects; T-Lymphocytes/immunology; T-Lymphocytes/pathology; T-Lymphocytes, Regulatory/pathology

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Diltiazem / Nicardipine / Adjuvants, Immunologic / Kidney Transplantation / Cyclosporins Language: En Journal: Am J Nephrol Year: 1990 Type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links